15-Minutes Built Up Screen
Wockhardt was in action on Monday after the drug maker said the US health regulator agreed to abridged clinical trials for antibiotic being developed by the company. Wockhardt recorded a jump of 6.46 percent in share price on Monday.
The company is developing superdrug antibiotic WCK 5222. The drug is expected to be a life-saving therapy for serious hospital acquired infections. The aforesaid US FDA approval will help Wockhardt to speed up phase III clinical trials for the drug.
To spot opportunities in the today’s fast-paced stock markets, day traders need access to advanced trading tools such as 15-minutes built up screen. It detects intra-day bullish/ bearish trend for a stock or an index futures by monitoring open interest (OI), price and volume every 15-minutes. By using 15-minutes built up screen, traders can identify where the short or long positions are created in real-time. It can help traders to make timely entry and exit from long or short positions.